ENOVIS CORP (ENOV)
US1940141062 - Common Stock
Overall ENOV gets a fundamental rating of 3 out of 10. We evaluated ENOV against 190 industry peers in the Health Care Equipment & Supplies industry. ENOV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ENOV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ENOV had positive earnings in the past year.
In the past year ENOV had a positive cash flow from operations.
In multiple years ENOV reported negative net income over the last 5 years.
ENOV had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ENOV has a better Return On Assets (-1.50%) than 68.42% of its industry peers.
With a decent Return On Equity value of -2.48%, ENOV is doing good in the industry, outperforming 71.58% of the companies in the same industry.
ENOV's Return On Invested Capital of 0.42% is fine compared to the rest of the industry. ENOV outperforms 67.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.5% | ||
| ROE | -2.48% | ||
| ROIC | 0.42% |
ROA(3y)-0.07%
ROA(5y)-1.35%
ROE(3y)0.06%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV has a better Operating Margin (1.45%) than 67.89% of its industry peers.
In the last couple of years the Operating Margin of ENOV has declined.
Looking at the Gross Margin, with a value of 58.12%, ENOV is in line with its industry, outperforming 54.21% of the companies in the same industry.
In the last couple of years the Gross Margin of ENOV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.45% | ||
| PM (TTM) | N/A | ||
| GM | 58.12% |
OM growth 3Y-44.8%
OM growth 5Y-32.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.34%
GM growth 5Y11.84%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
The number of shares outstanding for ENOV has been increased compared to 1 year ago.
Compared to 5 years ago, ENOV has more shares outstanding
Compared to 1 year ago, ENOV has a worse debt to assets ratio.
2.2 Solvency
ENOV has an Altman-Z score of 1.28. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ENOV (1.28) is comparable to the rest of the industry.
ENOV has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
ENOV has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: ENOV outperforms 41.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.28 |
ROIC/WACC0.05
WACC9.02%
2.3 Liquidity
ENOV has a Current Ratio of 2.10. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.10, ENOV is not doing good in the industry: 68.95% of the companies in the same industry are doing better.
A Quick Ratio of 1.03 indicates that ENOV should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.03, ENOV is not doing good in the industry: 81.58% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.13% over the past year.
Measured over the past years, ENOV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.18% on average per year.
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 14.02% in the last year.
Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -4.89% on average per year.
EPS 1Y (TTM)5.13%
EPS 3Y-16.82%
EPS 5Y-19.18%
EPS Q2Q%13.64%
Revenue 1Y (TTM)14.02%
Revenue growth 3Y-17.77%
Revenue growth 5Y-4.89%
Sales Q2Q%27.11%
3.2 Future
Based on estimates for the next years, ENOV will show a very strong growth in Earnings Per Share. The EPS will grow by 21.62% on average per year.
The Revenue is expected to grow by 11.58% on average over the next years. This is quite good.
EPS Next Y11.26%
EPS Next 2Y14.42%
EPS Next 3Y16.45%
EPS Next 5Y21.62%
Revenue Next Year25.01%
Revenue Next 2Y15.87%
Revenue Next 3Y13.16%
Revenue Next 5Y11.58%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ENOV is valuated rather expensively with a Price/Earnings ratio of 18.23.
Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 88.42% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ENOV to the average of the S&P500 Index (28.42), we can say ENOV is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.27, ENOV is valued correctly.
Based on the Price/Forward Earnings ratio, ENOV is valued cheaper than 89.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.02. ENOV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.23 | ||
| Fwd PE | 14.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaper than 87.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.08 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ENOV's earnings are expected to grow with 16.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y14.42%
EPS Next 3Y16.45%
5. Dividend
5.1 Amount
No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ENOVIS CORP
NYSE:ENOV (6/14/2024, 7:05:42 PM)
After market: 44.84 0 (0%)44.84
-0.07 (-0.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.46B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.23 | ||
| Fwd PE | 14.27 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.5% | ||
| ROE | -2.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.45% | ||
| PM (TTM) | N/A | ||
| GM | 58.12% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.1 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)5.13%
EPS 3Y-16.82%
EPS 5Y
EPS Q2Q%
EPS Next Y11.26%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.02%
Revenue growth 3Y-17.77%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y